Table of contents

Volume 85, Issue 1
Published online 3 July 2001 (1-140)

Top

Regular Articles

Adjuvant high-dose medroxyprogesterone acetate for early breast cancer: 13 years update in a multicentre randomized trial FREE

C Focan, M Beauduin, E Salamon, J de Greve, G de Wasch, J P Lobelle, F Majois, A Tagnon, J Tytgat, S van Belle, R Vandervellen and A Vindevoghel for the Adjuvant Breast Cancer Project Belgium

Br J Cancer 85: 1-8; doi:10.1054/bjoc.2001.1829

Fractionated administration of irinotecan and cisplatin for treatment of non-small-cell lung cancer: a phase II study of Okayama Lung Cancer Study Group FREE

H Ueoka, M Tanimoto, K Kiura, M Tabata, N Takigawa, Y Segawa, I Takata, K Eguchi, N Okimoto, S Harita, H Kamei, T Shibayama, Y Watanabe, S Hiraki and M Harada

Br J Cancer 85: 9-13; doi:10.1054/bjoc.2001.1861

Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis of published data FREE

D Choma, J-P Daurès, X Quantin and J L Pujol

Br J Cancer 85: 14-22; doi:10.1054/bjoc.2001.1892

Body surface area estimation in children using weight alone: application in paediatric oncology FREE

I Sharkey, A V Boddy, H Wallace, J Mycroft, R Hollis and S Picton on behalf of the Chemotherapy Standardisation group of the United Kingdom Children's Cancer Study Group

Br J Cancer 85: 23-28; doi:10.1054/bjoc.2001.1859

A randomized controlled trial to evaluate the role of interferon as initial and maintenance therapy in patients with follicular lymphoma FREE

A Rohatiner, J Radford, D Deakin, H Earl, S B Love, O Price, A Wilson and T A Lister

Br J Cancer 85: 29-35; doi:10.1054/bjoc.2001.1822

CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers FREE

L Kadouri, D F Easton, S Edwards, A Hubert, Z Kote-Jarai, B Glaser, F Durocher, D Abeliovich, T Peretz and R A Eeles

Br J Cancer 85: 36-40; doi:10.1054/bjoc.2001.1777

Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study FREE

D Stockton, V R Doherty and D H Brewster

Br J Cancer 85: 41-45; doi:10.1054/bjoc.2001.1699

Risk factors for cancer of the oral cavity and oro-pharynx in Cuba FREE

L Fernandez Garrote, R Herrero, R M Ortiz Reyes, S Vaccarella, J Lence Anta, L Ferbeye, N Muñoz and S Franceschi

Br J Cancer 85: 46-54; doi:10.1054/bjoc.2000.1825

Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas FREE

L L Groft, H Muzik, N B Rewcastle, R N Johnston, V Knäuper, M A Lafleur, P A Forsyth and D R Edwards

Br J Cancer 85: 55-63; doi:10.1054/bjoc.2001.1854

Mutations of the beta - and bold gamma -catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas FREE

M Ueda, R M Gemmill, J West, R Winn, M Sugita, N Tanaka, M Ueki and H A Drabkin

Br J Cancer 85: 64-68; doi:10.1054/bjoc.2001.1863

Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers FREE

Z Jin, G Tamura, T Tsuchiya, K Sakata, M Kashiwaba, M Osakabe and T Motoyama

Br J Cancer 85: 69-73; doi:10.1054/bjoc.2001.1853

Plasma insulin-like growth factor binding protein-3 proteolysis is increased in primary breast cancer FREE

S I Helle, S Geisler, T Aas, T Paulsen, J M P Holly and P E Lønning

Br J Cancer 85: 74-77; doi:10.1054/bjoc.2001.1860

Cellular mechanisms of bone resorption in breast carcinoma FREE

N C A Hunt, Y Fujikawa, A Sabokbar, I Itonaga, A Harris and N A Athanasou

Br J Cancer 85: 78-84; doi:10.1054/bjoc.2001.1856

Prognostic impact of urokinase-type plasminogen activator receptor (uPAR) in cytosols and pellet extracts derived from primary breast tumours FREE

J H de Witte, J A Foekens, N Brünner, J J T M Heuvel, ThH van Tienoven, M P Look, J G M Klijn, A Geurts-Moespot, N Grebenchtchikov, ThJ Benraad and C G J Sweep

Br J Cancer 85: 85-92; doi:10.1054/bjoc.2001.1867

Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer FREE

I Hashimoto, J Kodama, N Seki, A Hongo, M Yoshinouchi, H Okuda and T Kudo

Br J Cancer 85: 93-97; doi:10.1054/bjoc.2001.1846

Tcf-3 expression and beta -catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour) FREE

S Tejpar, C Li, C Yu, R Poon, H Denys, R Sciot, E Van Cutsem, J J Cassiman and B A Alman

Br J Cancer 85: 98-101; doi:10.1054/bjoc.2001.1857

Quantitative measurement of thyroglobulin mRNA in peripheral blood of patients after total thyroidectomy FREE

T Takano, A Miyauchi, H Yoshida, Y Hasegawa, K Kuma and N Amino

Br J Cancer 85: 102-106; doi:10.1054/bjoc.2001.1904

High density oligonucleotide array analysis of interferon-alpha2a sensitivity and transcriptional response in melanoma cells FREE

U Certa, M Seiler, E Padovan and G C Spagnoli

Br J Cancer 85: 107-114; doi:10.1054/bjoc.2001.1865

Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions FREE

N M Finnegan, J F Curtin, G Prevost, B Morgan and T G Cotter

Br J Cancer 85: 115-121; doi:10.1054/bjoc.2001.1850

Low-dose retinoic acid enhances in vitro invasiveness of human oral squamous-cell-carcinoma cell lines FREE

D Uchida, H Kawamata, K Nakashiro, F Omotehara, S Hino, M O Hoque, N-M Begum, H Yoshida, M Sato and T Fujimori

Br J Cancer 85: 122-128; doi:10.1054/bjoc.2001.1862

Therapy of human non-small-cell lung carcinoma using antibody targeting of a modified superantigen FREE

G Forsberg, L Ohlsson, T Brodin, P Björk, P A Lando, D Shaw, P L Stern and M Dohlsten

Br J Cancer 85: 129-136; doi:10.1054/bjoc.2001.1891

Top

Letters to the Editor

Chemotherapy and quality of life in advanced NSCLC FREE

D Farrugia and R Lewis

Br J Cancer 85: 137; doi:10.1054/bjoc.2001.1851

Chemotherapy and quality of life in advanced NSCLC – reply FREE

Heather Anderson, Jim Carmichael, Marianne Nicolson, Penny Hopwood and Nick Thatcher

Br J Cancer 85: 137-138; doi:10.1054/bjoc.2001.1852

Evaluating new treatments for advanced cancer FREE

Dr Nicholas Botwood

Br J Cancer 85: 139; doi:10.1054/bjoc.2001.1887

Evaluating new treatments for advanced cancer – reply FREE

Dr Jamie Ferguson

Br J Cancer 85: 139-140; doi:10.1054/bjoc.2001.1890

The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.

Extra navigation

ADVERTISEMENT